These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 21147032)
1. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Laurie SA; Ho AL; Fury MG; Sherman E; Pfister DG Lancet Oncol; 2011 Aug; 12(8):815-24. PubMed ID: 21147032 [TBL] [Abstract][Full Text] [Related]
2. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Dodd RL; Slevin NJ Oral Oncol; 2006 Sep; 42(8):759-69. PubMed ID: 16757203 [TBL] [Abstract][Full Text] [Related]
3. Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma. Ghosal N; Mais K; Shenjere P; Julyan P; Hastings D; Ward T; Ryder WD; Bruce I; Homer J; Slevin NJ Br J Oral Maxillofac Surg; 2011 Oct; 49(7):510-5. PubMed ID: 21071117 [TBL] [Abstract][Full Text] [Related]
4. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01). Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients. Couvreur K; Celine J; Marlies B; Randal D; Philippe D; Frederic D; Sylvie R Acta Clin Belg; 2020 Oct; 75(5):362-369. PubMed ID: 31232197 [TBL] [Abstract][Full Text] [Related]
6. Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma. Ross PJ; Teoh EM; A'hern RP; Rhys-Evans PH; Harrington KJ; Nutting CM; Gore ME Clin Oncol (R Coll Radiol); 2009 May; 21(4):311-4. PubMed ID: 19201585 [TBL] [Abstract][Full Text] [Related]
7. Systemic therapy in the management of metastatic or advanced salivary gland cancers. Lagha A; Chraiet N; Ayadi M; Krimi S; Allani B; Rifi H; Raies H; Mezlini A Oral Oncol; 2012 Oct; 48(10):948-957. PubMed ID: 22698431 [TBL] [Abstract][Full Text] [Related]
8. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548 [TBL] [Abstract][Full Text] [Related]
9. Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Hill ME; Constenla DO; A'Hern RP; Henk JM; Rhys-Evans P; Breach N; Archer D; Gore ME Oral Oncol; 1997 Jul; 33(4):275-8. PubMed ID: 9307718 [TBL] [Abstract][Full Text] [Related]
10. Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life. Locati LD; Galbiati D; Calareso G; Alfieri S; Singer S; Cavalieri S; Bergamini C; Bossi P; Orlandi E; Resteghini C; Platini F; Granata R; Quattrone P; Mancinelli M; Mariani L; Lo Vullo S; Licitra LF Cancer; 2020 Jan; 126(9):1888-1894. PubMed ID: 32031693 [TBL] [Abstract][Full Text] [Related]
11. Response to paclitaxel in adenoid cystic carcinoma of the salivary glands. Till BG; Martins RG Head Neck; 2008 Jun; 30(6):810-4. PubMed ID: 17979110 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983 [TBL] [Abstract][Full Text] [Related]
13. Rare breast metastasis from adenoid cystic carcinoma of the submandibular gland. Krucoff KB; Shammas RL; Stoecker M; Tolnitch LA BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30068574 [TBL] [Abstract][Full Text] [Related]
14. Systemic therapy in the palliative management of advanced salivary gland cancers. Laurie SA; Licitra L J Clin Oncol; 2006 Jun; 24(17):2673-8. PubMed ID: 16763282 [TBL] [Abstract][Full Text] [Related]
15. A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC. Chau NG; Hotte SJ; Chen EX; Chin SF; Turner S; Wang L; Siu LL Ann Oncol; 2012 Jun; 23(6):1562-70. PubMed ID: 22080184 [TBL] [Abstract][Full Text] [Related]
16. Preliminary experience with chemotherapy in advanced salivary gland neoplasms. Belani CP; Eisenberger MA; Gray WC Med Pediatr Oncol; 1988; 16(3):197-202. PubMed ID: 2837623 [TBL] [Abstract][Full Text] [Related]
17. Response to oxaliplatin with cetuximab in minor salivary gland adenoid cystic carcinoma. De Dosso S; Mazzucchelli L; Ghielmini M; Saletti P Tumori; 2009; 95(3):378-81. PubMed ID: 19688981 [TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Alcedo JC; Fábrega JM; Arosemena JR; Urrutia A Head Neck; 2004 Sep; 26(9):829-31. PubMed ID: 15350030 [TBL] [Abstract][Full Text] [Related]